TSS
CHRS icon

Two Sigma Securities’s Coherus Oncology CHRS Stock Holding History

Two Sigma Securities’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,587
Closed -$20.7K – 1718
2025
Q4 		$20.7K Sell
14,587
-119
-0.8% -$173 ﹤0.01% 1175
2025
Q3 		$24.1K Buy
+14,706
New +$16.4K ﹤0.01% 1105
2024
Q4 		– Sell
-21,594
Closed -$22.5K – 1880
2024
Q3 		$22.5K Buy
+21,594
New +$29.6K ﹤0.01% 2481
2023
Q4 		– Sell
-13,762
Closed -$51.5K – 3083
2023
Q3 		$51.5K Buy
+13,762
New +$63.6K ﹤0.01% 2472

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return